Daily 10 mg rivaroxaban as a therapy for ventricular thrombus related to left ventricular non-compaction cardiomyopathy: A case report.

ABSTRACT:

Rationale

Left ventricular non-compaction cardiomyopathy (LVNC) is a rare heart disorder related to thrombosis. Anticoagulant therapy is suggested for the treatment of this disease. The success of the novel oral anticoagulant rivaroxaban as a treatment option for this disorder is unclear.

Patient concerns

A 43-year-old man who felt dizzy at rest was found to have an intraventricular thrombus.

Diagnoses

The thrombus was confirmed by echocardiography. And LVNC was diagnosed by cardiac magnetic resonance (CMR) and echocardiography.

Interventions

He was prescribed a low dose (10 mg daily) of rivaroxaban as treatment.

Outcomes

After 3 months, the thrombus diminished, and the manifestation disappeared.

Lessons

Low dose of rivaroxaban may serve as a viab

SUBMITTER: Sun H 

PROVIDER: S-EPMC5794369 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature